Cell type–specific gene therapy confers protection against motor neuron disease caused by a TFG variant is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Institute of General Medical Sciences
Grant: GM134865
HHS | NIH | National Institute of General Medical Sciences
Grant: GM141013
HHS | NIH | National Institute of General Medical Sciences
Grant: GM108538
HHS | NIH | National Institute of General Medical Sciences
Grant: GM118110
HHS | NIH | National Institute of Neurological Disorders and Stroke
Grant: NS124165
HHS | NIH | National Cancer Institute
Grant: CA014520
HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
Grant: HD105353
NIGMS NIH HHS
Grant: T32 GM141013
NICHD NIH HHS
Grant: P50 HD105353
NIGMS NIH HHS
Grant: P41 GM108538
NINDS NIH HHS
Grant: R01 NS124165
NCI NIH HHS
Grant: P30 CA014520
NIGMS NIH HHS
Grant: R35 GM118110
NIGMS NIH HHS
Grant: R35 GM134865
FWCI
0.55
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals